Correlates for disease progression and prognosis during concurrent HIV/TB infection
Authors:
- Joel Fleury Djoba SiawayaJSJoel Fleury Djoba Siawaya
- Morten RuhwaldMRMorten Ruhwald
- Jesper Eugen-OlsenJEJesper Eugen-Olsen
- Gerhard WalzlGWGerhard Walzl
- 1 July 2007
- journal article
- review article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 11 (4) , 289-299
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapyClinical and Experimental Immunology, 2006
- Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment respondersClinical and Experimental Immunology, 2006
- Structure of Human Urokinase Plasminogen Activator in Complex with Its ReceptorScience, 2006
- The role of dendritic cells during infectionJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2003
- Serum HIV–1 RNA Levels Compared to Soluble Markers of Immune Activation to Predict Disease Progression in HIV–1–Infected IndividualsInternational Archives of Allergy and Immunology, 1998
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- The Role of β 2 -Microglobulin in Peptide Binding by Class I MoleculesScience, 1990
- The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.Journal of Experimental Medicine, 1984